Surveillance of breast cancer after primary treatment

Basit Öğe Kaydı
dc.contributor.authorKaradayi B.
dc.contributor.authorDirier A.
dc.contributor.authorZincircio?lu S.B.
dc.date.accessioned2024-04-24T17:58:35Z
dc.date.available2024-04-24T17:58:35Z
dc.date.issued2004
dc.departmentDicle Üniversitesien_US
dc.description.abstractBreast cancer occupies a serious part of routine oncological practice and medical care costs because of its high prevalance and long survival. Hence, surveillance after primary treatment should be based on evidence-based and cost-effective approach. Breast cancer recurrence can be seen as locoregional or systemic relapse, or both. The majority of relapses occur within first few years after treatment. Except mammography, laboratory and radiographic tests are not sensitive and specific enough for detecting recurrence. And early diagnosis of distant metastasis did not improved overall survival and quality of life in randomized clinical trials. Thus follow-up with clinical history, physical examination, patient education and annual mammography and pelvic examination is satisfactory for asymptomatic breast cancer patients after primary treatment.en_US
dc.identifier.endpage231en_US
dc.identifier.issn1301-8825
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-13244262761en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage224en_US
dc.identifier.urihttps://hdl.handle.net/11468/24007
dc.identifier.volume14en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofTHOD - Turk Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreast Neoplasmen_US
dc.subjectNeoplasm Recurrenceen_US
dc.titleSurveillance of breast cancer after primary treatmenten_US
dc.title.alternativeMeme kanserinde birincil tedavi sonrasi takipen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu